Figure 6
From: Assessment of total hepatitis C virus (HCV) core protein in HCV-related mixed cryoglobulinemia
HCV-Cp concentrations under treatment schedules comprising rituximab followed by pegylated interferon-α and ribavirin (A) and the simultaneous administration of these drugs (B).